Jupiter Life Line Hospitals Limited (NSE: JLHL, BSE: 543980) announced its unaudited financial results for the quarter ended December 31, 2025. The company recorded consolidated revenue growth of 9.78% year-over-year while managing non-recurring exceptional costs related to new labor regulations.
The company released its unaudited financial results for the third quarter of the 2026 fiscal year on January 30, 2026. The company reported a consolidated revenue of ₹3,653.67 million for the quarter, compared to ₹3,328.07 million in the same period the previous year. Net profit for the quarter stood at ₹424.98 million, a decrease from ₹522.16 million in the prior year’s corresponding quarter.
Company Profile and Business Model
Jupiter Life Line Hospitals Limited is primarily engaged in providing healthcare services in India. The healthcare segment constitutes its only reportable business and geographical segment. The company’s business model includes the operation of hospitals and related medical services through various subsidiaries and partnership firms. Key subsidiaries include Jupiter Hospital Projects Private Limited, Medulla Healthcare Private Limited, and Jupiter Hospital Pharmacy Private Limited.
Latest Quarterly Results and Highlights
• Consolidated Revenue: Total income for the quarter ended December 31, 2025, reached ₹3,744.96 million.
• Expenses: Total consolidated expenses for the quarter were ₹3,111.90 million, up from ₹2,732.82 million in the previous year.
• Exceptional Items: The company recorded an exceptional loss of ₹63.96 million on a consolidated basis.
• Segment Performance: The healthcare division remains the dominant revenue driver. The hotel division’s contribution to total revenue, profit, and assets remains below the 10% reportable threshold.
Regulatory Milestones and Segment Updates
On November 21, 2025, the Government of India notified four new Labour Codes: the Code on Wages, the Industrial Relations Code, the Code on Social Security, and the Occupational Safety, Health and Working Conditions Code. These codes consolidated 29 existing labor laws. JLHL assessed the financial implications of these codes, resulting in an increase in gratuity liability due to past service costs. This non-recurring impact totaled ₹63.96 million for the Group and ₹55.44 million for the standalone entity.
Full Year and Nine-Month Growth Context
For the nine months ended December 31, 2025, JLHL reported consolidated revenue of ₹11,119.49 million. This represents growth over the ₹9,657.41 million reported for the same period in the previous fiscal year. Consolidated net profit for the nine-month period was ₹1,439.20 million, compared to ₹1,484.72 million in the prior year. For the full fiscal year ended March 31, 2025, the company previously recorded total consolidated income of ₹13,307.49 million.
Management Commentary and Market Situation
The company is managed by Dr. Ankit Thakker, Joint Managing Director and CEO. As of December 31, 2025, the paid-up equity share capital of the company stood at ₹655.66 million, with shares having a face value of ₹10 each. The company maintains a presence in major Maharashtra markets, including Thane and Pune.
Guidance and Future Outlook
JLHL continues to monitor the finalization of Central and State Rules and clarifications from the Government regarding the new Labour Codes. The company intends to provide appropriate accounting effects as further developments occur. The management remains focused on its primary healthcare services segment as the core driver of future value.
Where Does Jupiter Life Line Hospitals Limited Stand Today?
As of the January 30, 2026, board meeting, JLHL continues to expand its consolidated operations while maintaining compliance with Indian Accounting Standards (Ind AS). The company’s financial structure includes multiple subsidiaries and partnership firms, some of which are currently under dissolution, such as Jupiter Gait Lab and Mangleshwar Hospitality. The company maintains its corporate headquarters in Thane, Maharashtra.